Evaluation of MRI Sequences in Hepatic Overload (HEPAT_MR)

March 10, 2021 updated by: Rennes University Hospital

Evaluation of MRI Sequences in Hepatic Overload.

MRI, without any contrast injection, allows a non-invasive evaluation and quantification of hepatic overloads, especially iron (liver iron content LIC) and fat (steatosis) overloads, but in certain clinical circumstances, cases require to improve performances. The aim of the study is to add to MRI scans which currently must be performed innovative sequences appropriate for the clinical question to overall appreciate on a varied range of patients their quality, their robustness, their relative performance and, for patients having a biopsy, their accuracy.

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

706

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Rennes, France, 35033
        • Rennes University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients with or suspected clinically to be with a hepatic overload pathology (hepatic iron and/or fat overload)

Description

Inclusion Criteria:

  • Men and women ≥ 18 years of age
  • Patients with or suspected clinically to be with a hepatic overload pathology (hepatic iron and/or fat overload) and who need a diagnostic or pre-therapeutic MRI from his initial management or during his monitoring,
  • Patient able to provide written informed consent and can understand and comply with the requirements of the study
  • Patient having received the information about the protocol and having not expressed his opposition to participate.

Exclusion Criteria:

Due to MRI :

  • pacemaker or defibrillator,
  • MRI non-compatible heart valve,
  • clips, stents, coils, etc… non-compatible with MRI,
  • cochlear implants,
  • neuronal or peripheric simulator,
  • intra-orbital or encephalic metallic foreign body, foreign body close to eyes, foreign body near the eyes, injury by metallic luster (war, ball),
  • endoprosthesis received since less than 4weeks and osteosynthesis equipment received since less than 6 weeks,
  • claustrophobia,
  • pump, tattoo, permanent make-up, intrauterine device, patch,
  • metal, magnetic, non-removable and in the area of the analyse field material

Other criteria :

  • unstable hemodynamic state, acute respiratory insufficiency, hemodynamically unstable acute respiratory failure, poor general condition or the necessity of a continuous monitoring incompatible with the MRI constraint,
  • adults legally protected (under judicial protection, guardianship, or supervision), persons deprived of their liberty,
  • pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation of the quantification deviations of hepatic iron and fat overloads between the new sequences and the conventional sequences.
Time Frame: 18 months
Evaluation of the robustness and the relative accuracy, comparison of sequences currently performed in daily clinical practice, of hepatic iron and fat content quantification with non-invasive new abdominal MRI sequences.
18 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Analysis of the accuracy of quantification: of the iron concentration against biochemical, semi-quantitative histological or subtracted iron volume compared to the hepatic volume analysis
Time Frame: 18 months
Evaluation of the accuracy of these new MRI sequences for hepatic iron and fat quantification, when patients have had in their normal care and management a biopsy or a bleedings subtracted iron volume leading to a desaturation.
18 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 4, 2013

Primary Completion (Actual)

December 19, 2018

Study Completion (Actual)

December 19, 2018

Study Registration Dates

First Submitted

May 27, 2013

First Submitted That Met QC Criteria

May 30, 2013

First Posted (Estimate)

May 31, 2013

Study Record Updates

Last Update Posted (Actual)

March 11, 2021

Last Update Submitted That Met QC Criteria

March 10, 2021

Last Verified

March 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 2013-A00197-38

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Iron and Fat Hepatic Overload

Subscribe